T
22.40
0.85 (3.94%)
Previous Close | 21.55 |
Open | 21.79 |
Volume | 112,219 |
Avg. Volume (3M) | 213,761 |
Market Cap | 418,264,000 |
Price / Book | 1.34 |
52 Weeks Range | |
Earnings Date | 12 Aug 2025 - 18 Aug 2025 |
Diluted EPS (TTM) | -3.14 |
Total Debt/Equity (MRQ) | 0.87% |
Current Ratio (MRQ) | 22.92 |
Operating Cash Flow (TTM) | -62.89 M |
Levered Free Cash Flow (TTM) | -69.56 M |
Return on Assets (TTM) | -22.89% |
Return on Equity (TTM) | -41.60% |
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (US) | Bearish | Bearish |
Biotechnology (Global) | Bearish | Bearish | |
Stock | Tectonic Therapeutic, Inc. | Bearish | Bullish |
AIStockmoo Score
0.3
Analyst Consensus | 1.0 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 0.25 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. |
|
Sector | Healthcare |
Industry | Biotechnology |
% Held by Insiders | 38.29% |
% Held by Institutions | 59.50% |
Ownership
Name | Date | Shares Held |
---|---|---|
Tfg Asset Management Gp Ltd | 31 Mar 2025 | 187,500 |
52 Weeks Range | ||
Price Target Range | ||
High | 101.00 (Wells Fargo, 350.89%) | Buy |
Median | 93.00 (315.18%) | |
Low | 85.00 (Mizuho, 279.46%) | Buy |
Average | 93.00 (315.18%) | |
Total | 2 Buy | |
Avg. Price @ Call | 20.92 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Mizuho | 15 May 2025 | 85.00 (279.46%) | Buy | 20.69 |
21 Apr 2025 | 51.00 (127.68%) | Buy | 17.92 | |
Wells Fargo | 21 Mar 2025 | 101.00 (350.89%) | Buy | 21.15 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |